Evolva Holding (ELVAF) Stock Price & Analysis
ELVAF Stock Chart & Stats
- Day’s Range
- $2.15 - $2.15
- 52-Week Range
- $1.10 - $2.15
- Previous Close
- $2.15
- Volume
- 20
- Average Volume (3M)
- 0
- Market Cap
- $19.87M
- Enterprise Value
- $13.09M
- Total Cash (Recent Filing)
- $4.22M
- Total Debt (Recent Filing)
- $0
- Price to Earnings (P/E)
- ―
- Beta
- -0.22
- Next Earnings
- Feb 19, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Low Financial Leverage
No debt from 2023–2025 limits interest-bearing obligations and reduces balance-sheet strain. This gives Evolva greater financial flexibility to preserve resources, pursue its ingredient and biotechnology activities, or withstand operating volatility without added lender pressure.
Reduced Cash Burn
The significant reduction in cash burn during 2024–2025 is a constructive operational trend, even though cash flow remained negative. Continued progress could extend financial runway and improve the company’s ability to stabilize operations without relying as heavily on external funding.
2024 Profitability Spike
Positive net income, EBIT and EBITDA in 2024 show that Evolva has demonstrated the ability to reach profitability under favorable conditions. If that performance could be repeated, it would support better capital preservation and indicate potential operating leverage in the business model.
Bears Say
Zero Recent Revenue
Revenue dropping to zero in both 2024 and 2025 indicates that Evolva currently lacks a durable operating revenue base. Without recurring sales, the company has limited evidence of commercial scale, making future profitability and self-funded growth dependent on rebuilding meaningful business activity.
Persistent Cash Consumption
Negative operating and free cash flow across every year from 2020–2025 shows that the business has consistently consumed cash rather than funded itself. This weak cash-generation profile can erode financial resources over time and restrict investment, commercialization, and strategic flexibility.
Volatile Profitability
Profitability has been highly unstable, with large losses through 2023, a positive result in 2024, and a return to losses in 2025. This inconsistency weakens confidence in sustainable earnings power and makes it difficult to determine whether the business can create lasting shareholder value.
Evolva Holding News
ELVAF FAQ
What was Evolva Holding’s price range in the past 12 months?
What is Evolva Holding’s market cap?
When is Evolva Holding’s upcoming earnings report date?
How were Evolva Holding’s earnings last quarter?
Is Evolva Holding overvalued?
Does Evolva Holding pay dividends?
What is Evolva Holding’s EPS estimate?
How many shares outstanding does Evolva Holding have?
What happened to Evolva Holding’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Evolva Holding?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Evolva Holding
EvoNext Holdings SA is dedicated to the exploration, creation, and distribution of pioneering ingredients across the nutritional, health, and wellness domains. Founded in 2004, the company's inception is attributed to Alexandra Santana Sørensen, Søren V. S. Nielsen, and Neil Goldsmith. Its corporate headquarters are located in Reinach, Switzerland.
- Sector
- Financial
- Industry
- Shell Companies
- CEO
- Gerhard Lobmaier
- Employees
- 49
- Website
- evonextholdings.com
- Address
- Angensteinerstrasse 6, Reinach, BL, 4153, CH
Evolva Holding (ELVAF) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 11 | 0 | 4 |
| Technical Analysis | 2 | 0 | 1 |
| Moving Averages | 9 | 0 | 3 |







